TickerFacts.

Immunovant, Inc. (IMVT): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

182.42M
Year ended 2026-03-31
+14.0%
3-year compound annual growth
+15.8%
5-year compound annual growth
2021-03-31: 87.76M2022-03-31: 109.68M2023-03-31: 123.08M2024-03-31: 138.10M2025-03-31: 151.57M2026-03-31: 182.42M182.42M
2021-03-31 Weighted Average Diluted Shares (shares) 2026-03-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2026-03-31182.42M+20.4%2026-05-20, From 2025-04-01
2025-03-31151.57M+9.8%2026-05-20, From 2024-04-01
2024-03-31138.10M+12.2%2026-05-20, From 2023-04-01
2023-03-31123.08M+12.2%2025-05-29, From 2022-04-01
2022-03-31109.68M+25.0%2023-05-22, From 2021-04-01
2021-03-3187.76Mn/a2022-06-08, From 2020-04-01